Like you gogo, I can't reconcile those sort of lab results and the outstanding PhII PFS result (which was statistically significant, despite the smaller trial size) with what we've heard today.
I also can't reconcile the improved FOLFIRI results with previous trials.
It's almost as if someones dropped all the results on the floor, picked them up in random order and split them in half! Either that or there was an error in drug supply.
At least there are another 2 trials coming that might shed more light on the technology.
Add to My Watchlist
What is My Watchlist?